ALSP is a rare neurodegenerative condition of the brain white matter. There are currently no FDA-approved treatments for ALSP. The objective of this project is to support a conference which brings together physicians, scientists, patients, caregivers and a stem cell center to foster the alignment of these contributors toward the development of cell therapies for this disease.